JUL 26, 2016 6:49 AM PDT

Brain Trauma Patients At High Risk for Blood Clots

WRITTEN BY: Kara Marker
Trauma patients rushed into the hospital are at a great risk for complications from blood clots, and some researchers believe quick application of blood clot prophylaxis is the key to reducing this risk. Other researchers are afraid that administering these drugs too soon is too risky - putting trauma patients at risk for intracranial hemorrhage. To settle the debate once and for all, researchers from the American College of Surgeons conducted a study. 

Anticoagulants, or blood-thinning drugs, like heparin work by decreasing the clotting ability of the blood cells by boosting the activity of an anti-clotting protein. Heparin is often used to treat blood clots in many situations, but concerned researchers thought that traumatic brain injury patients might be too vulnerable to excessive, fatal bleeding if a blood-thinning drug were to push them over the edge soon after their injury. 

On the other side of the argument, researchers believed that not only was using anticoagulants early on in brain trauma patients, but it was also preventative of future, potentially fatal clotting conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE). Traumatic brain injury patients are likely to remain sitting down for extended periods of time, and combined with their condition, they are at an especially high risk for DVT and PE. Researchers on the early prophylaxis side of the argument wanted to prove that administering anticoagulants 72 hours after hospital arrival and even earlier was both safe and effective for preventing blood clots.

Researchers gathered data from almost three thousand adult patients from the American College of Surgeons Trauma Quality Improvement Program (TQIP), all who experienced severe traumatic brain injury between 2012 and 2014. 

“By limiting our cohort to patients with isolated severe traumatic brain injury, we were able to minimize confounding due to other injuries in multiple body regions, while ensuring that our results are generalizable to patients with the most severe head injuries,” said lead study author James P. Byrne, MD. 

Did they receive prophylaxis with heparin? Was their treatment early (72 hours after hospital arrival and earlier) or late (after 72 hours)? Did they experience worsening intracranial hemorrhage, DVT, PE, surgical operations 72 hours after hospital admission, or in-hospital death? The researchers asked all of these questions and compared results between “early” and “late” prophylactic treatment groups. 

Their results led to their study being the first to ever show the safety of early prophylaxis as well as its ability to lower the risk of PE and DVT: odds of both of the clotting conditions in the early prophylaxis group were 50 percent lower compared to the late prophylaxis group. There was also no difference between the early and late prophylaxis groups per the incidence of neurosurgical interventions or in-hospital death, proving its safety. 

Severe brain trauma is very common in patients treated for major injuries at trauma centers, and for the researchers at the American College of Surgeons to confidently say from their findings that early prophylaxis is safe and effective at preventing PE and DVT, it means that many lives will hopefully be saved in the future with the administration of quick blood clot prophylaxis. 

This study was recently published in the Journal of the American College of Surgeons.
 


Source: American College of Surgeons, U.S. Food and Drug Administration, Circulation
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 18, 2019
Cardiology
JUN 18, 2019
Defining Cardiogenic Shock, New Guidelines
Cardiogenic shock (CS) occurs when the heart suddenly is unable to pump sufficient blood to meet the body’s needs. Most often, this condition is caus...
JUN 18, 2019
Cardiology
JUN 18, 2019
New Noninvasive Method For Controlling Atrial Fibrillation
Atrial fibrillation or Afib is a condition in which the heartbeat is irregular. Often the pulse is rapid in Afib patients as the heart attempts to maintain...
OCT 17, 2019
Cardiology
OCT 17, 2019
Runner's Knee, a Rundown
Perhaps you have taken up a running or another cardiovascular activity to protect your health as you age. This is, of course, a wise and proactive thing to...
NOV 07, 2019
Clinical & Molecular DX
NOV 07, 2019
A Revealing Look at Rare Disease Incidence
Being diagnosed with a rare disease can be especially terrifying for patients. After all, many of these diseases have no treatment options. This is because...
NOV 18, 2019
Cannabis Sciences
NOV 18, 2019
Frequent Marijuana Use Linked with Stroke and Arrhythmia
Research from two new preliminary studies presented at the American Heart Association’s (AHA) annual Scientific Sessions this week warned of the heal...
DEC 20, 2019
Health & Medicine
DEC 20, 2019
Potential Link Between Cannabis Use and Structural Changes to the Heart
Researchers from the Queen Mary University of London used MRI images of more than 3,000 people, 152 of them former or current cannabis users, to identify a...
Loading Comments...